Cell and Gene Therapy Manufacturing Market to Reach USD 146.2 Billion by 2032 Amid Rising Demand for Personalized Therapies, Viral Vector Capacity, and Automated Bioprocessing ...

The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...
BioPharma Dive

Why it’s critical to close open steps in cell therapy manufacturing

Cell therapy manufacturing is uniquely vulnerable to contamination, variability, and operational burden because the product - ...
GEN

Advanced Analytics Platform for Cell Therapy Manufacturing and Access

Cell therapy, one of the most promising frontiers in modern medicine, holds the potential to cure once-incurable diseases such as cancer and genetic disorders. But for all its promise, manufacturing ...
FiercePharma

Astellas, Yaskawa cement deal for robotic cell therapy production joint venture

With the power of robotics and the personalized medicine expertise of one of Japan's top drugmakers, Astellas Pharma and Yaskawa Electric Corporation are setting off on a joint venture to help ...
NJBIZ

Cellares expands global reach with cell therapy tech

The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...
Business Wire

GeminiBio Collaborates with Tolemy Bio to Launch aiMOS™, the First AI-Enabled Media Optimization Service for Cell Therapy Manufacturing

GeminiBio provides serum, customized media, buffers, and process liquids to biopharma and advanced therapy companies focused on the research and production of mRNA, AAV, monoclonal antibody, and cell ...

Cell and Gene Therapy CDMO Market Size to be Worth USD 29.49 Billion by 2035; Growth is Driven by Increasing Number of Advanced Therapies Globally

U.S. Cell and Gene Therapy CDMO Market is projected to grow from USD 2.09 Billion in 2025 to USD 10.28 Billion by 2035 due to expanding gene and cell therapy pipelines globallyAustin, March 06, 2026 ...

$14+ Bn Cell Therapy Manufacturing Market Trends and Forecasts, 2035 - Researchers are Exploring Over 1,000 Cell and Gene Therapy Candidates Targeting a Wide Range of Disease ...

The cell therapy manufacturing market offers significant opportunities driven by technological advancements, increasing clinical trials, and growing regulatory approvals. Key growth catalysts include ...
Business Wire

Cellares’ Cell Shuttle™ Receives FDA Advanced Manufacturing Technology (AMT) Designation for Automated Cell Therapy Manufacturing

The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...
Seeking Alpha

Robotics Transforms Cell Therapy: Multiply Labs Drives Staggering 74% Cost Reduction, Unlocking Global Patient Access

Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...
Nasdaq

Astellas and YASKAWA Agree to Establish a Joint Venture Focused on Cell Therapy Manufacturing

- Joint venture will aim to develop a cell therapy manufacturing platform through robotics and will offer access to startups and academic institutions - In the pharmaceutical industry, the ...